Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Evaluate Tolerability and Safety of HY209 in Healthy Volunteers
- First Posted Date
- 2024-08-01
- Last Posted Date
- 2024-08-15
- Lead Sponsor
- Kukjeon Pharmaceutical Co.,Ltd.
- Target Recruit Count
- 59
- Registration Number
- NCT06533878
- Locations
- 🇰🇷
Kukjeon Pharmaceutical Co., Ltd., Anyang-Si, Gyeonggi-Do, Korea, Republic of
News
No news found